- Home
- LSPD vs AGIO Comparison
LSPD vs AGIO Comparison
Compare LSPD & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSPD
- AGIO
- Stock Information
- Founded
- LSPD 2005
- AGIO 2007
- Country
- LSPD Canada
- AGIO United States
- Employees
- LSPD N/A
- AGIO N/A
- Industry
- LSPD
- AGIO Biotechnology: Pharmaceutical Preparations
- Sector
- LSPD
- AGIO Health Care
- Exchange
- LSPD Nasdaq
- AGIO Nasdaq
- Market Cap
- LSPD 2.7B
- AGIO 2.6B
- IPO Year
- LSPD 2020
- AGIO 2013
- Fundamental
- Price
- LSPD $17.28
- AGIO $53.78
- Analyst Decision
- LSPD Buy
- AGIO Buy
- Analyst Count
- LSPD 14
- AGIO 7
- Target Price
- LSPD $18.68
- AGIO $52.33
- AVG Volume (30 Days)
- LSPD 1.0M
- AGIO 726.1K
- Earning Date
- LSPD 11-07-2024
- AGIO 10-31-2024
- Dividend Yield
- LSPD N/A
- AGIO N/A
- EPS Growth
- LSPD N/A
- AGIO N/A
- EPS
- LSPD N/A
- AGIO 11.80
- Revenue
- LSPD $1,013,184,000.00
- AGIO $32,871,000.00
- Revenue This Year
- LSPD $23.40
- AGIO $33.38
- Revenue Next Year
- LSPD $18.81
- AGIO $163.06
- P/E Ratio
- LSPD N/A
- AGIO $4.56
- Revenue Growth
- LSPD 24.73
- AGIO 36.79
- 52 Week Low
- LSPD $11.01
- AGIO $20.96
- 52 Week High
- LSPD $21.71
- AGIO $62.58
- Technical
- Relative Strength Index (RSI)
- LSPD 62.66
- AGIO 59.21
- Support Level
- LSPD $16.62
- AGIO $43.25
- Resistance Level
- LSPD $18.88
- AGIO $62.58
- Average True Range (ATR)
- LSPD 0.60
- AGIO 2.73
- MACD
- LSPD 0.20
- AGIO 0.71
- Stochastic Oscillator
- LSPD 61.14
- AGIO 54.47
About LSPD Lightspeed Commerce Inc. Subordinate Voting Shares
Lightspeed Commerce Inc provides an omni-channel commerce-enabling SaaS platform. Its software platform provides customers with the functionality it needs to engage with consumers, manage their operations, accept payments, and grow their businesses. The company sells its platform through a direct sales force in the United States, Canada, New Zealand, United Kingdom, Australia, Germany, and other countries. It derives a majority of its revenue from the United States.
About AGIO Agios Pharmaceuticals Inc.
Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development plan for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval.